Methylphenobarbital
NERVOUS SYSTEM
Also known as: mephobarbital, mephobarbitone, methylphenobarbitone, metylfenemal
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Methylphenobarbital is a drug catalogued in DrugCentral. It was first approved by the YEAR INTRODUCED in 1935. DrugCentral lists 1 molecular target, including GABRA1|GABRG2|GABRB3. Recorded indications include Anxiety, Apprehension, Epilepsy and Tension.
- Molecular targets: GABRA1|GABRG2|GABRB3 (1 listed in DrugCentral).
- Indications: Anxiety, Apprehension, Epilepsy, Tension and Tonic-clonic epilepsy.
- ATC code: N03AA01 (Barbiturates and derivatives).
- Molecular formula: C13H14N2O3; molecular weight 246.27 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (5)
- Anxiety
- Apprehension
- Epilepsy
- Tension
- Tonic-clonic epilepsy
Contraindications (21)
- Acute exacerbation of asthma
- Alcoholism
- Anemia
- Chronic obstructive lung disease
- Depressive disorder
- Disease of liver
- Hepatic coma
- Hepatic encephalopathy
- Hepatic failure
- Hyperactive behavior
- Hyperammonemia
- Kidney disease
- Neutropenic disorder
- Porphyria
- Pregnancy, function
- Respiratory insufficiency
- Sleep apnea
- Sleep automatism
- Substance abuse
- Suicidal thoughts
- Thrombocytopenic disorder
Mechanism & targets
Molecular targets (1)
| Target | Gene | Action | Activity |
|---|---|---|---|
| GABA-A receptor alpha-1/beta-3/gamma-2 | GABRA1|GABRG2|GABRB3 | unknown | — |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1935-01-01 | YEAR INTRODUCED | — | — |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
N03AA01 | NERVOUS SYSTEM › ANTIEPILEPTICS › ANTIEPILEPTICS › Barbiturates and derivatives |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Methylphenobarbital is on its molecule page.
| Molecular formula | C13H14N2O3 |
|---|---|
| Molecular weight | 246.27 g/mol |
| CAS number | 115-38-8 |
| InChIKey | ALARQZQTBTVLJV-UHFFFAOYSA-N |
| PubChem CID | 8271 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Methylphenobarbital used for?
DrugCentral lists the following indications for Methylphenobarbital: Anxiety, Apprehension, Epilepsy, Tension and Tonic-clonic epilepsy.
How does Methylphenobarbital work?
Its molecular targets in DrugCentral include GABRA1|GABRG2|GABRB3.
When was Methylphenobarbital first approved?
Methylphenobarbital was first approved by the YEAR INTRODUCED in 1935.
What is the chemical formula of Methylphenobarbital?
Methylphenobarbital has the molecular formula C13H14N2O3 and a molecular weight of 246.27 g/mol.
Browse: all drugs starting with M · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1696 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL45029 — compound record and bioactivity
- PubChem CID 8271 — chemical identifiers
- DrugBank DB00849 — drug record
- FDA UNII 5NC67NU76B — substance identity
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.